Johnson & Johnson (NYSE: JNJ) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 2%
Johnson & Johnson (JNJ) Q3 earnings: Infographic
Categories
Health Care
AstraZeneca stock looks a good bet as COVID antibody drug brings fresh hope
With the pandemic situation showing little signs of improvement, healthcare institutions are under pressure to expedite their vaccine development programs, amid growing
OXFORD BIOMEDICA PLC (OXB) Q2 2020 Earnings Call Transcript
OXFORD BIOMEDICA PLC (OTC: OXB) Q2 2020 earnings call dated Sep. 17, 2020 Corporate Participants: Catherine Isted -- Head of Corporate Development
Innate Pharma S.A. (IPHA) Q2 2020 Earnings Call Transcript
Innate Pharma S.A. (NASDAQ: IPHA) Q2 2020 earnings call dated Sep. 08, 2020. Corporate Participants: Mondher Mahjoubi -- Chairman of the Executive Board and
UnitedHealth Group (UNH) is headed for a weak second half. Here’s why
For UnitedHealth Group Inc. (NYSE: UNH), the early effect of coronavirus on its business was a marked reduction in costs due to
Bristol Myers looks to expand cardiovascular portfolio with MyoKardia acquisition
Bristol Myers Squibb (NYSE: BMY) agreed to acquire MyoKardia Inc. (NASDAQ: MYOK) for $13.1 billion in cash. The deal, which amounts to
Auris Medical Holding AG (EARS) Q2 2020 Earnings Call Transcript
Auris Medical Holding AG (NASDAQ: EARS) Q2 2020 earnings call dated Sep. 17, 2020. Corporate Participants: Thomas Meyer -- Chief Executive Officer
New Frontier Health Corporation (NFH) Q2 2020 Earnings Call Transcript
New Frontier Health Corporation (NYSE: NFH) Q2 2020 earnings call dated Aug. 27, 2020 Corporate Participants: William Zima -- Investor Relations Roberta
Applied Genetic Technologies Corp. (AGTC) Q4 2020 Earnings Call Transcript
Applied Genetic Technologies Corp. (NASDAQ: AGTC) Q4 2020 earnings call dated Sep. 09, 2020 Corporate Participants: Sue Washer -- President and Chief Executive Officer
After initial hiccups, Cigna (CI) looks to emerge healthier post-COVID
The healthcare sector was required to respond to the coronavirus outbreak in a proactive manner, unlike most other businesses. Cigna Corporation (NYSE:
Trinity Biotech plc (TRIB) Q2 2020 Earnings Call Transcript
Trinity Biotech plc (NASDAQ: TRIB) Q2 2020 earnings call dated Aug. 25, 2020 Corporate Participants: Kevin Tansley -- Chief Financial Officer Ronan O'Caoimh -- Chairman and
Lannett Inc. (LCI) Q4 2020 Earnings Call Transcript
Lannett Inc. (NYSE: LCI) Q4 2020 earnings call dated Aug. 26, 2020 Corporate Participants: Robert Jaffe -- Investor Relations, Robert Jaffe Co., LLC Timothy
AMAG Pharmaceuticals Inc (AMAG) Q2 2020 Earnings Call Transcript
AMAG Pharmaceuticals Inc (NASDAQ: AMAG) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Rushmie Nofsinger -- Executive Director of Corporate Communications &
Ascendis Pharma A/S (ASND) Q2 2020 Earnings Call Transcript
Ascendis Pharma A/S (NASDAQ: ASND) Q2 2020 earnings call dated Aug. 27, 2020 Corporate Participants: Scott T. Smith -- Senior Vice President and Chief
AngioDynamics Inc. (ANGO) Q1 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q1 2021 earnings call dated Sep. 29, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Key highlights from AngioDynamics (ANGO) Q1 2021 earnings results
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by
Palatin Technologies Inc. (PTN) Q4 2020 Earnings Call Transcript
Palatin Technologies Inc (NYSEAMERICAN : PTN) Q4 2020 earnings call dated Sep. 28, 2020 Corporate Participants: Carl Spana -- President and Chief Executive Officer
What makes CVS Health a better investment option than Walgreens
https://www.youtube.com/watch?v=WOSh4S0zUds For healthcare systems across the world, currently, the first priority is to find an effective treatment for coronavirus, at a time
Misonix Inc. (MSON) Q4 2020 Earnings Call Transcript
Misonix Inc. (NASDAQ: MSON) Q4 2020 earnings call dated Sep. 03, 2020 Corporate Participants: Norberto Aja -- Investor Relations Stavros George Vizirgianakis -- President and Chief
Phreesia, Inc. (PHR) Q2 2021 Earnings Call Transcript
Phreesia, Inc. (NYSE: PHR) Q2 2021 earnings call dated Sep. 09, 2020 Corporate Participants: Balaji Gandhi -- Investor Relations Chaim Indig -- Chief Executive Officer Tom
Flower One Holdings Inc. (FONE) Q2 2020 Earnings Call Transcript
Flower One Holdings Inc. (CNSX: FONE) Q2 2020 earnings call dated Sep. 09, 2020 Corporate Participants: Ken Villazor -- President & Chief Executive Officer